Recombinant Human SSTR2 Protein (HEK293)

SSTR2, or Somatostatin Receptor Type 2, is a G-protein-coupled receptor that plays a crucial role in various physiological processes, including the regulation of endocrine functions and neuroendocrine tumors. The research surrounding SSTR2 has gained significant attention due to its implications in cancer biology, particularly in neuroendocrine tumors where it is often overexpressed. This receptor is a primary target for somatostatin analogs, which are used in both diagnostic imaging and therapeutic applications for conditions like acromegaly and carcinoid syndrome. The characterization of SSTR2 recombinant proteins is vital for understanding its structure-function relationship, signaling pathways, and interactions with potential therapeutic agents. By producing and purifying these recombinant proteins, researchers can investigate various aspects, such as receptor-ligand binding, cellular signaling mechanisms, and the development of novel therapeutics. This research not only enhances our understanding of SSTR2's role in normal physiology but also aids in the development of targeted therapies for SSTR2-expressing tumors. As such, ongoing studies focus on optimizing the expression and purification methods of SSTR2 recombinant proteins to facilitate structural and functional analyses, ultimately contributing to the advancement of precision medicine strategies in oncology.